Restoring Gut Metabolites Helps Multiple Sclerosis
Author Information
Author(s): Jank Larissa, Singh Saumitra S, Lee Judy, Dhukhwa Asmita, Siavoshi Fatemeh, Joshi Deepika, Minney Veronica, Gupta Kanak, Ghimire Sudeep, Deme Pragney, Schoeps Vinicius A, Soman Karthik, Ladakis Dimitrios, Smith Matthew, Borkowski Kamil, Newman John, Baranzini Sergio E, Waubant Emmanuelle L, Fitzgerald Kathryn C, Mangalam Ashutosh K, Haughey Norman, Kornberg Michael D, Chamling Xitiz, Calabresi Peter A, Bhargava Pavan
Primary Institution: Cold Spring Harbor Laboratory
Hypothesis
Oral supplementation of indole lactate (ILA) can positively impact multiple sclerosis (MS) disease processes.
Conclusion
Supplementing with ILA may reduce neuroinflammation and promote remyelination in multiple sclerosis.
Supporting Evidence
- ILA reduces neuroinflammation by dampening immune cell activation.
- ILA promotes remyelination and oligodendrocyte differentiation.
- Supplementation of ILA restores the gut microbiome's metabolic balance.
- A lower ILA:IAA ratio correlates with worse MS outcomes.
Takeaway
Giving a special type of gut metabolite called indole lactate to people with multiple sclerosis can help their nerves heal and reduce inflammation.
Methodology
The study used two preclinical models to assess the effects of ILA on MS-related processes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website